Safety Profile Based on Concordance of Nonclinical Toxicity and Clinical Adverse Drug Reactions for Blood Cancer Drugs Approved in Japan
Crossref DOI link: https://doi.org/10.1007/s40268-016-0160-x
Published Online: 2016-12-19
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kubota, Sachie http://orcid.org/0000-0002-6211-9061
Saito, Kazuyuki
Ono, Shunsuke
Kodama, Yasuo
License valid from 2016-12-19